Use of dipeptidyl peptidase-4 inhibitors is associated with a lower risk of rheumatoid arthritis in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of cohort studies
Nipith Charoenngam, Thanitsara Rittiphairoj, Ben Ponvilawan, Patompong Ungprasert
Topics & Concepts
MedicineMeta-analysisInternal medicineRheumatoid arthritisHazard ratioType 2 Diabetes MellitusCohortCohort studyDipeptidyl peptidase-4 inhibitorRelative riskRetrospective cohort studyDiabetes mellitusConfidence intervalEndocrinologyRheumatoid Arthritis Research and TherapiesDiabetes Treatment and ManagementPeptidase Inhibition and Analysis